Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK
Neurological Sciences · 2024
DOI: 10.1007/s10072-024-07336-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, 2024. Verfasst von Ali Abbasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: UCB Pharma Ltd., 208 Bath Road, Slough, SL1 3WE, UK. ali.abbasi@ucb.com. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neuron Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: UCB Celltech.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UCB Pharma Ltd., 208 Bath Road, Slough, SL1 3WE, UK. ali.abbasi@ucb.com.
- UCB Pharma Ltd., 208 Bath Road, Slough, SL1 3WE, UK.
- UCB Pharma, Raleigh, USA.
- UCB Pharma, Braine, Belgium.
Förderung
- UCB Celltech
Zitieren
APA
Abbasi, A., Fryk, H., Rudnik, J., White, R., Vanderkelen, M., Scowcroft, A., & Bonar, K. (2024). Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK. Neurological Sciences. https://doi.org/10.1007/s10072-024-07336-8
Vancouver
Abbasi A, Fryk H, Rudnik J, White R, Vanderkelen M, Scowcroft A, et al. Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK. Neurological Sciences. 2024. doi:10.1007/s10072-024-07336-8
BibTeX
@article{Abbasi2024,
author = {Abbasi, Ali and Fryk, Henrik and Rudnik, Jan and White, Richard and Vanderkelen, Mark and Scowcroft, Anna and Bonar, Kerina},
title = {Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK},
journal = {Neurological Sciences},
year = {2024},
doi = {10.1007/s10072-024-07336-8}
}
EUVIMED